BIOHIT OYJ'S FINANCIAL INFORMATION IN 2010
BIOHIT OYJ STOCK EXCHANGE RELEASE ON 31 DECEMBER 2009 AT 12:45
BIOHIT OYJ'S FINANCIAL INFORMATION IN 2010
Biohit Oyj will publish its financial information in 2010 as follows:
Financial Statement Bulletin 2009 Friday 12 Feb 2010 at 9:30 AM
Financial Statements 2009 Wednesday 31 March 2010
Interim Report January-March 2010 Friday 7 May 2010 at 9:30 AM
Interim Report January-June 2010 Friday 6 Aug 2010 at 9:30 AM
Interim Report January-September 2010 Friday 5 Nov 2010 at 9:30 AM
The Annual General Meeting of Biohit Oyj is planned to be held on Friday 23
April 2010. The meeting will be convened later on by the Board of Directors.
Stock exchange releases can be read online via Biohit's website at
www.biohit.com.
Biohit Oyj
Petteri Rehu
Financial Director
Further information:
Petteri Rehu, Financial Director
Tel: +358-9-773 861
Email: petteri.rehu@biohit.com
Distribution:
NASDAQ OMX Helsinki Ltd.
Central storage facility (www.oam.fi)
Press
www.biohit.com
About Biohit Oyj
Biohit Oyj develops, manufactures and markets liquid handling products and
diagnostic test systems for use in research, health care and industrial
laboratories.
Liquid handling products include electronic and mechanical pipettes and
dispensers, and disposable tips, as well as pipette maintenance and calibration
services. Diagnostics business comprises products and analysis systems for
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the
stomach and associated risks, as well as quick tests for the diagnosis of
lactose intolerance, H. pylori infection and fecal occult blood.
Biohit Group employs 370 people in 9 countries. Biohit Oyj is headquartered in
Finland. Subsidiaries are located in France, Germany, the UK, Russia, India,
China, Japan and the USA. Additionally, Biohit's products are sold by
approximately 450 distributors in 70 countries. Biohit's share (BIOBV) is quoted
on NASDAQ OMX Helsinki, Small cap/Healthcare.
Read more at www.biohit.com